AURKA and non-small cell lung carcinoma: In particular, studies have revealed that acquired resistance to EGFR-TKIs in NSCLC cells requires aurora kinase A activity and that EGFR-TKI-resistant NSCLC cells are sensitive to aurora kinase inhibitors [26].